OQROGet OQRO Pro
Insider trade

Rocket Pharmaceuticals (RCKT)See Remarks sold ~$34K

Jonathan David Schwartz, See Remarks at Rocket Pharmaceuticals, sold ~$34K of Rocket Pharmaceuticals shares.

~$34K
Approx. value · 11K sh @ $3.02
224K
Holds after · shares reported
Traded
Aug 14, 2025
Filed
Aug 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 3, 2025InsiderCFO sold ~$4.3K of RCKT shares in the open market
  2. Aug 14, 2025 · this disclosureInsiderOfficer sold ~$34K of RCKT shares in the open market

What came next

  1. Aug 14, 2025Insider · 2 peopleInsiders: 2 sales (~$58K)
  2. Aug 18, 2025Insider · 3 peopleInsiders: 3 sales (~$10K)
  3. Aug 19, 2025Insider · 3 peopleInsiders: 3 sales (~$5K)
  4. Aug 27, 2025InsiderDirector purchased ~$34K of RCKT shares in the open market
  5. Sep 11, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Sep 23, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 23, 2025, Dr. Gotham Makker resigned from the Board of Directors (the “Board”) of the Company, effectively as of September 24, 2025. Dr. Makker’s decision to resign from the Board did not involve any disagreement on any matter relating to the Company’s operations, policies or practices.”
  7. Sep 29, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 29, 2025, Pedro Granadillo resigned from the Board of Directors (the “Board”) of the Company, effective as of September 30, 2025. Mr. Granadillo’s decision to resign from the Board did not involve any disagreement on any matter relating to the Company’s operations, policies or practices.”
  8. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rocket Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Rocket Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RCKT page.

Other recent filings by Jonathan David Schwartz, See Remarks

The full history of Jonathan David Schwartz, See Remarks is on the profile page.

How this filing works

Other disclosures at Rocket Pharmaceuticals

Everything OQRO holds on this company is on its RCKT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data